The global pessary market is experiencing a significant upswing, with a valuation of US$ 350 million in 2024 and a promising forecast to reach US$ 700 million by the end of 2031. This remarkable growth trajectory reflects the increasing demand for pessaries as a vital alternative to surgical interventions for pelvic organ prolapse (POP) and urinary incontinence.
Germany: Germany's emphasis on high-quality healthcare, government initiatives supporting women's health, and rising health issues due to sedentary lifestyles drive pessary demand.
China: China's high market share in East Asia is propelled by its growing elderly population, a surge in female urinary incontinence cases, increased disposable income, and untapped growth opportunities in diagnostics.
This product will be delivered within 1-3 business days.
Key Market Drivers
The escalating prevalence of pelvic organ prolapse and urinary incontinence is a primary catalyst for the surge in demand for pessaries. These medical conditions often result in the displacement of vaginal tissues, requiring non-invasive support. Pessaries play a pivotal role in aiding women who may not be suitable candidates for surgery, offering a less complex and complication-prone solution.About Pessaries
A pessary is a soft, removable vaginal implant designed to provide support to prolapsed pelvic organs, such as the uterus, bladder, or rectum. Notably, vaginal pessaries are considered a first-line treatment for primary stress urinary incontinence due to their high success rates and low complication rates, especially among elderly women who are more susceptible to pelvic organ prolapse.Key Opportunities for Pessary Manufacturers
- The increasing prevalence of pelvic organ prolapse presents lucrative opportunities for pessary manufacturers.
- Concerns surrounding complex surgical procedures and post-operative complications bolster the appeal of pessaries as a preferred treatment option.
- Growing geriatric populations, lifestyle-associated diseases, and the proven effectiveness of pessaries contribute to rapid market expansion.
- The global elderly population is expected to more than double by 2050, further fueling demand for pessaries.
- Pregnancy-related pressure on pelvic floor muscles enhances the prospects for pessary usage in pregnant women.
Factors Limiting Demand Growth to Some Extent
While pessaries offer significant benefits, they are not without limitations:
- Prolonged use of pessaries can lead to urinary tract infections and other complications.
- Discomfort, side effects, and complications, including fistulas and erosion, can deter adoption.
- Finding the right pessary size and type for individual patients can be challenging.
- Insertion, removal, and associated discomfort may necessitate frequent doctor visits.
- Certain pessary types can cause difficulties during sexual intercourse.
Country-wise Insights
United States: With its increasing aging population, the United States continues to lead the North American pessary market. Pessaries are a preferred choice for patients unwilling or unsuitable for surgery, making them a crucial alternative treatment option.Germany: Germany's emphasis on high-quality healthcare, government initiatives supporting women's health, and rising health issues due to sedentary lifestyles drive pessary demand.
China: China's high market share in East Asia is propelled by its growing elderly population, a surge in female urinary incontinence cases, increased disposable income, and untapped growth opportunities in diagnostics.
Competitive Landscape
The pessary market boasts a highly fragmented landscape with numerous competitors. Companies are pursuing growth strategies such as mergers, acquisitions, partnerships, collaborations, and new product launches to meet demand and expand their customer base.Key Companies Profiled
- CooperSurgical Inc.
- Bliss GVS Pharma
- MedGyn
- Panpac Medical Corporation
- Bioteque America
- Personal Medical Corporation
- Dr. Arabin GmbH & Co.
- Kangge Medical
- Integra Lifesciences
- Wallach Surgical Devices
- Medesign
Pessary Industry Research Segmentation
By Product:
- Ring Pessaries
- Lever Pessaries
- Incontinence Rings
- Marland
- Gellhorn
- Gehrung
- Donuts
- Cubes
By Indication:
- Pelvic Organ Prolapse
- Urinary Incontinences
By End User:
- Hospitals
- Ambulatory Surgical Centres
- Speciality Clinics
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Market Overview
3. Global Pessary Market Outlook, 2018 - 2031
4. North America Pessary Market Outlook, 2018 - 2031
5. Europe Pessary Market Outlook, 2018 - 2031
6. Asia Pacific Pessary Market Outlook, 2018 - 2031
7. Latin America Pessary Market Outlook, 2018 - 2031
8. Middle East & Africa Pessary Market Outlook, 2018 - 2031
9. Competitive Landscape
10. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- CooperSurgical Inc
- Bliss GVS Pharma
- MedGyn
- Panpac Medical Corporation
- Bioteque America
- Personal Medical Corporation
- Dr.Arabin GmbH & Co.
- Kangge Medical
- Integra Lifesciences
- Wallach Surgical Devices
- Medesign
Methodology
LOADING...